QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast

Rhea-AI Summary

QIAGEN N.V. (NYSE: QGEN) has announced its upcoming fourth quarter and full-year 2022 results, set to be released on February 7 at 22:05 Frankfurt time. Following this, a conference call is scheduled for February 8 at 15:00 Frankfurt time, where key business updates and financial performance will be discussed. The company provides solutions in molecular diagnostics, applied testing, pharma, and academia, serving over 500,000 customers globally. As of September 30, 2022, QIAGEN employed over 6,200 people across 35 locations worldwide.

VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the fourth quarter and full-year 2022.

Press release date / time: Tuesday, February 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Wednesday, February 8, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.

Three options for joining the conference call

Register for call back connection   Click here: Connect me   Service available 15 minutes before call start

Dial-in by phone     +1 646 828 8193 (U.S.) +44 (0)330 165 3655 (UK) +49 (0)69 2222 25574 (GER)   To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.   Conference ID: 5239371

Access the audio webcast   Click here: Access Webcast

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1584746&tp_key=0a3819b11c

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of September 30, 2022, QIAGEN employed more than 6,200 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230117005645/en/

John Gilardi

Vice President, Head of Corporate Communications and Investor Relations

+49 2103 29 11711

+49 152 018 11711

+1 240 686 2222

Email: ir@qiagen.com

Phoebe Loh

Senior Director Investor Relations

+49 2103 29 11457

+49 152 018 11457

Email: ir@qiagen.com

Source: QIAGEN N.V.

FAQ

When will QIAGEN release its fourth quarter and full-year 2022 results?

QIAGEN will release its results on February 7, 2023, at 22:05 Frankfurt time.

What time is the QIAGEN conference call scheduled?

The conference call will take place on February 8, 2023, at 15:00 Frankfurt time.

How can I join the QIAGEN conference call?

You can join the QIAGEN conference call via a dial-in phone number or by accessing the audio webcast.

What is QIAGEN's stock symbol?

QIAGEN's stock symbol is QGEN.

What services does QIAGEN provide?

QIAGEN provides sample to insight solutions for molecular diagnostics and other sectors, serving over 500,000 customers worldwide.